Interestingly, ERK2 knockdown leads to increased expression levels of liprin-β2 in MDA-MB-231 breast cancer cells and liprin-β2 knockdown restores the invasive phenotype of ERK2-depleted cells in three-dimensional ECM [75]. Here, MAPK1 is linked to breast carcinoma.